XML 14 R2.htm IDEA: XBRL DOCUMENT v3.25.0.1
Condensed Consolidated Interim Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2024
Sep. 30, 2024
Current    
Cash and cash equivalents $ 120,775 $ 132,187
Incentive and tax receivables 2,557 2,449
Prepaid expenses and other current assets 711 931
Total Assets 124,043 135,567
Current Liabilities    
Accounts payable 4,567 9,627
Accrued liabilities - Note 3 7,732 4,835
Deferred grant income - Note 4 829 842
Total Liabilities 13,128 15,304
Commitments and Contingencies - Note 6
Capital stock Authorized:10,000,000 preferred stock, par value $0.001 per share
Capital stock Authorized:200,000,000 common stock, par value $0.001 per share 84,985,449 common shares (September 30, 2024 - 84,795,517) 85 85
Additional paid-in capital 459,012 456,249
Accumulated deficit (348,182) (336,071)
Total Stockholders’ Equity 110,915 120,263
Total Liabilities and Stockholders’ Equity $ 124,043 $ 135,567